Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
A conversation with Terrence Kalley, founder of Freedom of Access to Medicines (FAMEDS), regarding patient advocacy and his organization's fight against FDA's plans to remove the metastatic breast cancer indication for Avastin, a biologic drug produced and marketed by Genentech/Roche.
